Aged garlic extract therapy for sickle cell anemia patients by Takasu, Junichiro et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
BMC Blood Disorders
BMC Blood Disorders  2002,  2 x Research article
Aged garlic extract therapy for sickle cell anemia patients
Junichiro Takasu 1, Rolando Uykimpang 1, Maria Alenor Sunga 1, 
Harunobu Amagase 2 and Yutaka Niihara *1
Address: 1Department of Medicine, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance, CA and 2Wakunaga of America Co., Ltd., 
Mission Viejo, CA
E-mail: Junichiro Takasu - jtakasu@rei.edu; Rolando Uykimpang - yniihara@rei.edu; Maria Sunga - yniihara@rei.edu; 
Harunobu Amagase - yniihara@rei.edu; Yutaka Niihara* - yniihara@rei.edu
*Corresponding author
Abstract
Background: Sickle cell anemia is one of the most prevalent hereditary disorders with prominent
morbidity and mortality. With this disorder oxidative, phenomena play a significant role in its
pathophysiology. One of the garlic (Allium sativum L.) formulations, aged garlic extract (AGE), has
been reported to exert an anti-oxidant effect in vitro, we have evaluated the anti-oxidant effect of
AGE on sickle red blood cells (RBC).
Methods: Five patients (two men and three women, mean age 40 ± 15 years, range 24–58 years)
with sickle cell anemia participated in the study. AGE was administered at a dose of 5 ml a day.
Whole blood samples were obtained at baseline and at 4 weeks for primarily Heinz body analysis.
Results: The data were consistent with our hypothesis. In all patients, the number of Heinz bodies
decreased over the 4 week period (58.9 ± 20.0% at baseline to 29.8 ± 15.3% at follow-up, p = 0.03).
Conclusions: These data suggest that there is a significant anti-oxidant activity of AGE on sickle
RBC. AGE may be further evaluated as a potential therapeutic agent to ameliorate complications
of sickle cell anemia.
Background
Sickle cell disease is one of the most prevalent hereditary
disorders with prominent morbidity and mortality. While
the disease may affect various ethnic groups such as peo-
ple of Hispanic and Middle Eastern descent, it affects
those of African descent the most. Clinical manifestations
of sickle cell disease are largely due to a hemolytic process
leading to severe anemia and vasoocclusion resulting in
pain and organ damage. In the pathophysiology of sickle
cell disease, increased oxidant susceptibility of sickle red
blood cells (RBC) has been demonstrated to play a major
role [7,12,23,26,36,37,39].
Recent investigations have brought forth ample data that
support significant anti-oxidant activity of garlic (Allium
sativum L.) [2,11,15,18,40]. Among various preparations
of garlic supplements, aged garlic extract (AGE) in partic-
ular has been associated with anti-oxidant activities in
sound scientific experiments [2,14–20,38]. Therefore,
based on these data, we have examined the potential role
of AGE as an anti-oxidant in sickle cell disease.
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Methods
Aged garlic extract
Aged garlic extract (AGE, Kyolic), kindly provided by
Wakunaga of America (Mission Viejo, CA), is formulated
by soaking sliced raw garlic in 15–20% aqueous ethanol
for up to 20 months at room temperature. The extract is
then filtered and concentrated under reduced pressure at
low temperature. The content of water-soluble com-
pounds is relatively high, whereas that of oil-soluble com-
pounds is low. The AGE used in this trial contained 305 g/
l of extracted solids; S-allyl cysteine, the most abundant
water-soluble organosulfur compound in AGE, was
present at a concentration of 1.47 g/l.
Study population
The participants were those individuals with the estab-
lished diagnosis of sickle cell anemia (hemoglobin SS) by
hemoglobin electrophoresis and who were 18 years of age
or older. The exclusion criteria were any significant medi-
cal conditions other than sickle cell disease, including di-
abetes mellitus, renal failure or heart failure, pregnancy,
and history of treatment with any antisickling agents with-
in 12 months of initiation of this study. This project was
approved by Internal Review Board of Habor-UCLA Re-
search and Education Institute. All the participants are
volunteers and signed appropriate consent form after
careful explanation and review of the protocol.
Administration of aged garlic extract
After obtaining consent, each patient was seen at baseline
for interview, physical examination, and baseline blood
tests. Urine pregnancy test was also performed for each
woman of childbearing age. Participants were instructed
to self-administer liquid AGE at a dose of 5 ml twice daily.
At 4 weeks, the patients were reevaluated with a brief
physical examination and interview. Also, whole blood
samples were drawn for evaluations including the Heinz
body test.
Biochemical and physiological parameters
RBC count, hemoglobin
Coulter counter was used for determination of RBC
counts and hemoglobin levels.
Heinz body count
Heinz bodies were evaluated utilizing a standard method
using crystal violet solution [4,13,35]. The number of RBC
containing five or more Heinz bodies was counted in 100
RBC and expressed as a percentage.
Statistical analysis
All values are reported as mean ± SD. The paired t-test was
used to evaluate the differences of variables between base-
line and follow-up data. All tests of significance were 2
tailed, and significance was defined at p < 0.05.
Results
Five patients (two men and three women, mean age 40 ±
15 years, range 24–58 years) were entered into the study.
Table 1 summarizes the hematological data, RBC
glutamine content, and the results of the Heinz body anal-
ysis at baseline and after 4 weeks of administration of
AGE. (Figure 1) There were no significant changes in RBC
count, hemoglobin level, hematocrit or reticulocyte
count. However, the average Heinz body count decreased
from 58.9 to 29.8 percent (P < .03). In all patients, the av-
erage Heinz body count decreased significantly at 4 weeks
compared to the baseline.
Discussion
Recent studies [1,7,8,12,23,26–28,36,37,39] have shown
that oxidative phenomena plays a significant role in the
pathophysiology of sickle cell disease. The oxidant stress
may contribute to the sickling process with formation of
"dense cells"; the development of vasoocclusion; and
shortened RBC survival[7,12,23,26,36,37,39] The oxidant
damage in sickle RBC is most likely a consequence of the
inherent instability of hemoglobin S[1,28], which results
in a concomitant increase in free radical generation [12]
in association with impaired antioxidant defense
[7,8,26,27]. With sustained intracellular production of
oxygen free radicals, the three-dimensional structure of
hemoglobin is affected sufficiently to lower its solubility.
These factors lead to formation of Heinz bodies that are
aggregates of insoluble hemochromes [6].
The Heinz bodies, which adhere to the RBC membrane
[6], may themselves cause significant damage to the mem-
brane. In any case, assessment of Heinz bodies is a useful
gauge in evaluating susceptibility of RBC to the oxidant
stress [26,39]. In the study presented here, the data are
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preliminary in nature. However, AGE therapy was associ-
ated with decrease in Heinz bodies in sickle RBC in each
patient. The data were consistent with our hypothesis and
confirm the previous reports that demonstrated anti-oxi-
dant activities of AGE [2,14–20,38].
In regard to hematological parameters, AGE had no signif-
icant effect on RBC count, hemoglobin level and hemat-
ocrit. There are reports[5,21,24,25,29,31] that have
shown in animals that the garlic extract may affect the
RBC count adversely during the acute phase by inducing
hemolytic anemia. Ironically, these are thought to be
caused, at least partially, by oxidant stress caused by com-
pounds such as Allicin contained in the usual garlic ex-
tract. Allicin has been shown to enhance Low Density
Lipoprotein oxidation [19], and to oxidize the iron of he-
moglobin in RBC with methemoglobin formation[9].
AGE, on the other hand, has been processed to eliminate
these compounds by the aging process without loss of wa-
ter-soluble anti-oxidant compounds such as S-allyl-
cysteine and fructosyl arginine. One of these water soluble
compounds, S-allylcysteine has been shown specifically
to inhibited the formation of dense cells in in vitro study
of blood samples from sickle cell anemia patients [32,33].
Thus, AGE supposedly has decreased capacity for inducing
oxidant stress seen in usual garlic extracts [22], yet main-
tains its antioxidant activity [2,14–20,38]. In this study,
there were no adverse effects including those on hemato-
logical parameters during the few weeks of AGE adminis-
tration.
In conclusion, in a small cohort of sickle cell anemia pa-
tients, we have demonstrated an association of AGE ther-
apy with decrease in Heinz bodies in their RBC. One need
to be cautioned that the data presented here are prelimi-
nary and the study was an open labeled non-randomized
trial. However, the results are suggestive of potential effect
of AGE as an anti-oxidant in sickle RBC. Previously, AGE
has been shown to significantly improve erythrocyte de-
formability through stabilization of erythrocyte mem-
branes in non-sickle RBC [30]. These phenomenons were
attributed to the anti-oxidant activities of AGE [30]. At
baseline, erythrocyte deformability is further altered in
sickle RBC due to abnormal membrane that is highly per-
meable [10]. This abnormality is thought to be contribu-
tory, at least partially, in formation of dense cells [34]. The
dense cells, in turn, react with inflammatory cells and en-
dothelial cells leading to vasoocclusive changes [3]. Per-
haps AGE may also improve erythrocyte membrane
stability in sickle RBC with anti-oxidant activities as sug-
gested by the data presented here in which there were re-
duction of Heinz bodies in sickle RBC with daily AGE
administration. Again the data are preliminary in nature,
but they are consistent with previous findings regarding
anti-oxidant effect of AGE. With these data, further testing
is warranted for confirmation of the efficacy of this rela-
tively harmless agent in the management of sickle cell dis-
ease.
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